Innovation Hubs Director, ARISE
Dr Beverley Vaughan joined the Arise Innovation Hubs as Director in June 2021, with over 20 years’ experience in the healthcare and life sciences sector.
Beverley trained as a clinical scientist in Haematology and working at Cambridge and London University Hospitals.
Working in the innovation sector for the last 10 years with roles in Stevenage Bioscience Catalyst (SBC), Cell and Gene Therapy Catapult (CGT) and the University of Oxford in programme manager and director level positions.
Whilst at SBC Beverley supported the development of translational research facilities and raised funding from multiple pharma and biotech companies for the Open Innovation Challenge in Neurodegeneration. At CGT Beverley managed a wide portfolio of project from novel drug discovery spin outs to NHS led delivery of cell therapy products. Most recently she was responsible for the delivery of a drug discovery consortium-UKSPINE- pivoting traditional pathways to meet the demands of healthy aging with partners, Universities of Oxford, Dundee and Birmingham, Medicines Discovery Catapult, The Francis Crick Institute and Sanger Centre Cambridge.
Since joining Arise as Director Beverley has been working on building the life science strategy for their newest hub located on the Harlow Innovation Park, leading on strategy, fund raising and partnering activities to build a cluster of expertise within this synapse of the London-Cambridge corridor. She is also a member of the NC3Rs CRACKIT advisory panel.